Published in Vaccine Weekly, November 20th, 1995
Adenoviral vectors represent a highly efficient method of transducing specific genes into a host cell. However, despite the high transduction rate, its ability to express target genes is limited. Adenoviral vectors elicit a host immune response which induces the host to destroy the virus. Thus ending the beneficial effects of the whole gene therapy process.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.